Skip to main content
. 2020 Aug 10;2020:4174395. doi: 10.1155/2020/4174395

Table 2.

Efficacy outcomes.

Best response Chemotherapy + simvastatin (n = 40) Chemotherapy + placebo (n = 40) P value
n (%)
Complete response 1 (2.5) 4 (10) 0.57
Partial response 13 (32.5) 9 (22.5)
Stable disease 10 (25) 11 (27.5)
Progressive disease 14 (35) 15 (37.5)
Not evaluable 2 (5) 1 (2.5)

The assessment did not include the withdrawn consent patients (n = 2)